Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Yerushalmy-Feler A, Pujol-Muncunill G, Martin-de-Carpi J, Kolho KL, Levine A, Olbjørn C, Granot M, Bramuzzo M, Rolandsdotter H, Mouratidou N, Hradsky O, Scarallo L, Matar M, Rimon RM, Rinawi F, Shalem T, Najajra H, de Meij T, Aloi M, Rodríguez-Belvís MV, Alvisi P, Schneider AM, van Rheenen P, Navas-López VM, Kiparissi F, Barrio J, Turner D, Cohen S.
Yerushalmy-Feler A, et al. Among authors: shalem t.
J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):717-723. doi: 10.1097/MPG.0000000000003608. Epub 2022 Sep 8.
J Pediatr Gastroenterol Nutr. 2022.
PMID: 36084231